Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 16/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 11/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 8/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | AHCY | P23526 | 1/20 | 0.42 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL239657 | 1.00 | ADORA3 (0.51) | ADORA3ADORA1ADORA2AADORA2BAHCY | |
| SCHEMBL292844 | 1.00 | ADORA3 (0.51) | ADORA3ADORA1ADORA2AADORA2BAHCY | |
| SCHEMBL4436180 | 1.00 | ADORA3 (0.51) | ADORA3ADORA1ADORA2AADORA2BAHCY | |
| SCHEMBL2888630 | 0.93 | ADORA3 (0.58) | ADORA3ADORA1ADORA2AADORA2B | |
| Hydrochloric Acid SCHEMBL1402131 | 0.92 | ADORA3 (0.57) | ADORA3ADORA1ADORA2AADORA2B | |
| Hydrochloric Acid SCHEMBL1402127 | 0.92 | ADORA3 (0.57) | ADORA3ADORA1ADORA2AADORA2B | |
| Hydrochloric Acid SCHEMBL241332 | 0.92 | ADORA3 (0.57) | ADORA3ADORA1ADORA2AADORA2B | |
| Hydrochloric Acid SCHEMBL293315 | 0.92 | ADORA3 (0.57) | ADORA3ADORA1ADORA2AADORA2B | |
| Hydrochloric Acid SCHEMBL293316 | 0.92 | ADORA3 (0.57) | ADORA3ADORA1ADORA2AADORA2B | |
| Hydrochloric Acid SCHEMBL242624 | 0.92 | ADORA3 (0.57) | ADORA3ADORA1ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2013211-B1 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2012-03-14 | — | — | EP | disclosed |